Fuso Pharmaceutical Industries,Ltd. Logo

Fuso Pharmaceutical Industries,Ltd.

Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.

4538 | T

Overview

Corporate Details

ISIN(s):
JP3823600006
LEI:
Country:
Japan
Address:
大阪市中央区道修町一丁目7番10号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Fuso Pharmaceutical Industries, Ltd. is a manufacturer and seller of pharmaceuticals and medical equipment. Established in 1950, the company specializes in essential medical products, with a core portfolio centered on dialysis-related drugs, infusions, injections, and transfusion fluids. Fuso is actively involved in the research and development of new medicines, maintaining a pipeline of drugs in various clinical trial stages. The company's operations are guided by its mission of "Supporting Life, Nurturing Life," providing critical healthcare solutions to medical institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 04:14
Interim Report
確認書
Japanese 9.3 KB
2025-11-12 04:08
Interim Report
半期報告書-第103期(2025/04/01-2026/03/31)
Japanese 194.0 KB
2025-06-26 04:32
Post-Annual General Meeting Information
臨時報告書
Japanese 27.4 KB
2025-06-24 08:02
Governance Information
内部統制報告書-第102期(2024/04/01-2025/03/31)
Japanese 25.2 KB
2025-06-24 08:01
Registration Form
確認書
Japanese 9.4 KB
2025-06-24 08:00
Registration Form
有価証券報告書-第102期(2024/04/01-2025/03/31)
Japanese 1.0 MB
2025-06-03 10:03
Capital/Financing Update
臨時報告書
Japanese 22.6 KB
2025-05-28 09:44
Legal Proceedings Report
臨時報告書
Japanese 23.6 KB
2024-11-12 07:02
Interim Report
確認書
Japanese 9.3 KB
2024-11-12 07:01
Interim Report
半期報告書-第102期(2024/04/01-2025/03/31)
Japanese 189.2 KB
2024-06-26 03:18
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2024-06-25 09:19
Governance Information
内部統制報告書-第101期(2023/04/01-2024/03/31)
Japanese 24.1 KB
2024-06-25 09:17
Registration Form
確認書
Japanese 9.4 KB
2024-06-25 09:04
Registration Form
有価証券報告書-第101期(2023/04/01-2024/03/31)
Japanese 1019.3 KB
2024-05-13 10:14
Regulatory News Service
臨時報告書
Japanese 23.1 KB

Automate Your Workflow. Get a real-time feed of all Fuso Pharmaceutical Industries,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fuso Pharmaceutical Industries,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fuso Pharmaceutical Industries,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Laboratorio Reig Jofre S.A. Logo
A pharmaceutical company making essential health products accessible in over 70 countries.
Spain
RJF
Laboratorios Farmaceuticos Rovi S.A. Logo
Integrated pharma firm developing prescription drugs and offering contract manufacturing services.
Spain
ROVI
LakeShore Biopharma Co., Ltd. Logo
Develops vaccines and therapeutic biologics for infectious diseases and cancer.
United States of America
LSB
Lantern Pharma Inc. Logo
Leverages AI and machine learning to discover and develop targeted cancer therapies.
United States of America
LTRN
Lantheus Holdings, Inc. Logo
Develops radiopharmaceutical diagnostics and therapies to help clinicians fight disease.
United States of America
LNTH
LAVA Therapeutics NV Logo
Develops bispecific gamma delta T cell engagers for solid and hematologic cancers.
United States of America
LVTX
Lavipharm S.A. Logo
Develops & distributes Rx/OTC medicines, supplements & cosmetics for key therapeutic areas.
Greece
LAVI
Clinical-stage biopharma developing oral therapies for neuropsychiatric diseases like schizophrenia.
United States of America
LBRX
Legend Biotech Corp Logo
Develops and commercializes CAR-T cell therapies for cancer, including CARVYKTI® for myeloma.
United States of America
LEGN
LENZ Therapeutics, Inc. Logo
Develops a prescription eye drop for presbyopia, the age-related loss of near vision.
United States of America
LENZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.